stockrowLiquidia Corporation
LQDA Healthcare Drug Manufacturers Specialty & Generic
Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.
- Revenue
- +1,842.7%
- EPS
- +271.4%
- Free cash flow
- +270.2%
- Total debt
- −9.04%
Quarter to June 2026, against a year earlier
Follow LQDA
Alert me
Liquidia Corporation (LQDA) Return on invested capital
Liquidia Corporation's return on invested capital over the twelve months to 30 June 2026 was 121.1%, up 191.8 percentage points from fiscal 2025 (−70.7%). Over the past ten years it has ranged from −475.4% (fiscal 2023) to 0.00% (fiscal 2022); the current reading is higher than 38% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | −70.7% | 397.74 |
| FY2024 | −468.5% | 6.98 |
| FY2023 | −475.4% | (334.46) |
| FY2022 | −141.0% | (140.97) |
| FY2022 | 0.00% | 113.98 |
| FY2021 | −114.0% | (113.98) |
| FY2021 | 0.00% | 226.33 |
| FY2020 | −226.3% | (226.33) |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| SUPN Indivior Pharmaceuticals Inc. compare | 283.0% |
| LQDA Liquidia Corporation | 121.1% |
| LNTH Lantheus Holdings, Inc. compare | 14.6% |
| PBH Prestige Consumer Healthcare Inc. compare | 9.59% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 8.45% |
| AMLX Amylyx Pharmaceuticals, Inc. compare | 0.00% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 0.00% |
| RGC Regencell Bioscience Holdings Limited compare | 0.00% |
| HIMS Hims & Hers Health, Inc. compare | −11.4% |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on LQDA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement